Table 1 Primary and secondary outcomes of the trial
|  | Source of data (see Table 2 for details of each measure) | ||
|---|---|---|---|
Measure | End point | ||
3Â months | 12Â months | ||
Primary outcome | |||
 Percentage of days abstinent | Timeline Followback (TLFB) [28] | X |  |
Secondary outcomes | |||
 Percentage of days abstinent | TLFB [28] |  | X |
 Alcohol misuse | • Alcohol Use Disorders Identification Test (AUDIT) [23] • Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) [29] | X | X |
 Psychological distress | Kessler-10 (K10) [24] | X | X |
 Depression | Patient Health Questionnaire-9 (PHQ-9) [30] | X | X |
 Anxiety | Hopkins Symptom Checklist Anxiety (HSCL-A) [31] | X | X |
 Symptoms of PTSD | PTSD Checklist for DSM-5 (PCL-6) [32] | X | X |
 Functional disability | WHO Disability Assessment Schedule (WHODAS 2.0) [33] | X | X |
 Perpetration of intimate partner violence | United Nations Multi-Country Study on Men and Violence [34] | X | X |
 Health economic indicators | • EuroQol-5D-5L (EQ-5D-5L) [35] • Subjective wellbeing [36, 27] • Oxford Capabilities Mental Health questionnaire (OxCAP-MH) [37] • User cost questionnaire | X | X |